Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-IND-13-02
Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 121 al 140 de 230 resultados
PRUDENT: Prioritization, incentives and Resource use for sUstainable DENTistry STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 Oral diseases and conditions are the 3rd most expensive diseases to treat in the EU. They affect about half of the EU population. As highlig...
2023-01-01 - 2027-12-31 | Financiado
MARCHES: Methodologies for Assessing the Real Costs to Health of Environmental Stressors AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 To underpin regular use of integrated economic and health modeling in impact assessments and socio-economic analysis by public authorities,...
2023-01-01 - 2026-12-31 | Financiado
iPROLEPSIS: iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A... ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up...
2023-01-01 - 2026-12-31 | Financiado
ENDOTARGET: Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic target... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Rheumatic diseases (RDs) affect more than 40% of Europe's population and cause significant disability, pain, reduced lifespan and a very hig...
2023-01-01 - 2026-12-31 | Financiado
BoSS: Bauhaus of the Seas Sails ISTID ASSOCIACAO DO INSTITUTO SUPERIOR TECNICO PARA A INVESTIGACAO E O DESENVOLVIMENTO tramitó un HORIZON EUROPE: HORIZON-MISS-2021-NEB-01-01 "The vision of the BoSS project is to demonstrate and archive solutions for climate neutrality with a particular focus on coastal cities as...
2023-01-01 - 2025-12-31 | Financiado
MISTRAL: a toolkit for dynaMic health Impact analysiS to predicT disability-Related costs in the Aging popula... ISTITUTO SUPERIORE DI SANITA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 The environment is one of the most crucial determinants of health. The Global Burden of Disease report estimates an emerging impact in terms...
2023-01-01 - 2026-12-31 | Financiado
IMMEDIATE: Imminent Disease Prediction and Prevention at the Environment Host Interface CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 IMMEDIATE aims to investigate and explore the diet-microbiome-immunometabolism-axis as a sensor for health-to-disease transition and evaluat...
2023-01-01 - 2026-12-31 | Financiado
REALM: Real-world-data Enabled Assessment for heaLth regulatory decision-Making UNIVERSITEIT MAASTRICHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 The overall aim of the REALM project is to create a collaborative framework for regulatory authorities, application developers, healthcare p...
2023-01-01 - 2026-12-31 | Financiado
BoSS: Bauhaus of the Seas Sails ISTID ASSOCIACAO DO INSTITUTO SUPERIOR TECNICO PARA A INVESTIGACAO E O DESENVOLVIMENTO tramitó un HORIZON EUROPE: HORIZON-MISS-2021-NEB-01-01 "The vision of the BoSS project is to demonstrate and archive solutions for climate neutrality with a particular focus on coastal cities as...
2022-12-06 - 2025-12-31 | Financiado
PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-04 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado
EWALD: Earth Observation for Early Warning of Land Degradation at European Frontier COFAC COOPERATIVA DE FORMACAO E ANIMACAO CULTURAL CRL tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Land degradation (LD) is the world's greatest environmental challenge affecting the environment, agriculture, and human wellbeing. Intensifi...
2022-12-01 - 2026-11-30 | Financiado
UBIGIoT: Ultra-Low Design-Effort, Energy-Efficient and Battery-Indifferent Sensor Node for the Green Internet... UNIVERSITA DEGLI STUDI DI GENOVA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 "The rapid technological improvement in the semiconductor industry has enabled smaller and smaller devices to pervade our everyday lives. Th...
2022-12-01 - 2026-11-30 | Financiado
ONCOVALUE: Implementing value-based oncology care at European cancer hospitals: An AI-based framework for asses... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 ONCOVALUE will unlock the full potential of real world data (RWD) collected in European cancer hospitals and institutes to ease the decision...
2022-12-01 - 2026-11-30 | Financiado
SQUEEZE: Maximising Impact of Prescription Drugs in Rheumatoid Arthritis MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 The SQUEEZE consortium comprehensively addressed how biomarkers can be used to optimize disease modifying antirheumatic drugs (DMARDs) for r...
2022-12-01 - 2027-11-30 | Financiado
OPADE: Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi... FONDAZIONE EBRIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 280M of people worldwide suffers from major depressive disorders (MDD). Although a well-populated therapeutic landscape of anti-depre280M of...
2022-12-01 - 2027-05-31 | Financiado
PREVALUNG EU: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified i... INSTITUT GUSTAVE ROUSSY tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflammatory processes associated wit...
2022-12-01 - 2027-11-30 | Financiado
DYNAMO: Modelling and dynamic assessment of integrated health and care pathways enhancing response capacity... EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 DYNAMO will result in a lean and powerful solution enabling quick, data-driven and platform-independent planning of care pathways for situat...
2022-11-25 - 2026-02-28 | Financiado
VALESOR: VALUATION OF ENVIRONMENTAL STRESSORS UNIVERSITE DANGERS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 VALESOR aims to make major contributions to the scientific and policy efforts to accommodate economic values of environmental stressors more...
2022-11-25 - 2025-12-31 | Financiado
More-EUROPA: More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-02 While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world...
2022-11-24 - 2027-12-31 | Financiado
METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. Academisch Medisch Centrum AMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado